Shufro Rose & Co. LLC Has $392,000 Stock Holdings in Oracle Co. (NYSE:ORCL)

Shufro Rose & Co. LLC lessened its holdings in Oracle Co. (NYSE:ORCL) by 9.6% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 2,351 shares of the enterprise software provider’s stock after selling 249 shares during the quarter. Shufro Rose & Co. LLC’s holdings in Oracle were worth $392,000 as of its most recent SEC filing.

Other large investors have also recently modified their holdings of the company. Norges Bank acquired a new stake in shares of Oracle during the 4th quarter valued at $2,216,314,000. Raymond James Financial Inc. acquired a new stake in shares of Oracle during the 4th quarter valued at $930,095,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its holdings in shares of Oracle by 20.5% during the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 13,825,360 shares of the enterprise software provider’s stock valued at $2,303,858,000 after acquiring an additional 2,350,448 shares in the last quarter. Vanguard Group Inc. boosted its holdings in shares of Oracle by 1.5% during the 4th quarter. Vanguard Group Inc. now owns 157,411,949 shares of the enterprise software provider’s stock valued at $26,231,127,000 after acquiring an additional 2,296,069 shares in the last quarter. Finally, Kovitz Investment Group Partners LLC boosted its holdings in shares of Oracle by 268.4% during the 4th quarter. Kovitz Investment Group Partners LLC now owns 3,077,947 shares of the enterprise software provider’s stock valued at $512,909,000 after acquiring an additional 2,242,520 shares in the last quarter. Institutional investors and hedge funds own 42.44% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research firms recently weighed in on ORCL. Mizuho cut their price objective on Oracle from $210.00 to $180.00 and set an “outperform” rating on the stock in a report on Tuesday, April 15th. Westpark Capital initiated coverage on Oracle in a report on Tuesday, April 1st. They set a “buy” rating and a $195.00 target price on the stock. Cantor Fitzgerald cut their target price on Oracle from $214.00 to $175.00 and set an “overweight” rating on the stock in a report on Tuesday, March 11th. UBS Group reaffirmed a “market perform” rating on shares of Oracle in a report on Tuesday, March 11th. Finally, KeyCorp reaffirmed an “overweight” rating and set a $200.00 target price on shares of Oracle in a report on Tuesday, March 11th. Fourteen equities research analysts have rated the stock with a hold rating, fifteen have issued a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $174.42.

Oracle Stock Down 0.8%

ORCL stock opened at $156.04 on Monday. The stock’s 50 day simple moving average is $143.68 and its 200 day simple moving average is $161.83. Oracle Co. has a fifty-two week low of $114.55 and a fifty-two week high of $198.31. The company has a debt-to-equity ratio of 5.65, a quick ratio of 0.81 and a current ratio of 0.81. The company has a market cap of $436.44 billion, a P/E ratio of 38.15, a price-to-earnings-growth ratio of 3.46 and a beta of 1.27.

Oracle (NYSE:ORCL) last posted its quarterly earnings results on Monday, March 10th. The enterprise software provider reported $1.47 earnings per share for the quarter, missing analysts’ consensus estimates of $1.49 by ($0.02). Oracle had a return on equity of 133.25% and a net margin of 21.16%. The firm had revenue of $14.13 billion for the quarter, compared to analyst estimates of $14.40 billion. During the same period last year, the company posted $1.41 earnings per share. The firm’s quarterly revenue was up 6.4% compared to the same quarter last year. On average, research analysts expect that Oracle Co. will post 5 earnings per share for the current fiscal year.

Oracle Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, April 23rd. Shareholders of record on Thursday, April 10th were issued a dividend of $0.50 per share. This is a positive change from Oracle’s previous quarterly dividend of $0.40. This represents a $2.00 dividend on an annualized basis and a yield of 1.28%. The ex-dividend date was Thursday, April 10th. Oracle’s payout ratio is currently 46.95%.

Insiders Place Their Bets

In other Oracle news, Director Naomi O. Seligman sold 2,000 shares of the business’s stock in a transaction that occurred on Wednesday, April 2nd. The stock was sold at an average price of $145.81, for a total transaction of $291,620.00. Following the completion of the sale, the director now directly owns 34,630 shares of the company’s stock, valued at approximately $5,049,400.30. The trade was a 5.46% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Leon E. Panetta sold 17,500 shares of the business’s stock in a transaction that occurred on Friday, May 2nd. The stock was sold at an average price of $151.24, for a total value of $2,646,700.00. Following the sale, the director now directly owns 58,090 shares of the company’s stock, valued at $8,785,531.60. This represents a 23.15% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 27,366 shares of company stock valued at $4,015,723. Corporate insiders own 42.20% of the company’s stock.

About Oracle

Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.